__NUXT_JSONP__("/drugs/Pibrozelesin_Hydrobromide", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"148778-32-9",chebiId:"",chemicalFormula:"C32H36BrN5O8.BrH",definition:"The hydrobromide salt form of pibrozelesin, a semisynthetic water-soluble derivative of the antineoplastic antibiotic duocarmycin B2, with antineoplastic activity. Activated by carboxyl esterase, pibrozelesin alkylates DNA by binding to adenine-thymine (A-T)-rich sequences in the minor groove of DNA, thereby inhibiting DNA replication and inducing apoptosis.",fdaUniiCode:"0481JCC90T",identifier:"C73816",preferredName:b,semanticType:"Pharmacologic Substance",subclassOf:["C2156"],synonyms:["PIBROZELESIN HYDROBROMIDE",b]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FPibrozelesin_Hydrobromide",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Pibrozelesin_Hydrobromide","Pibrozelesin Hydrobromide","2021-10-30T13:44:09.313Z")));